# Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma

> **NCT02624440** · PHASE2 · UNKNOWN · sponsor: **Henrik Gregersen** · enrollment: 300 (estimated)

## Conditions studied

- Multiple Myeloma
- Infection

## Interventions

- **DRUG:** Standard myeloma treatment
- **DRUG:** Clarithromycin
- **DRUG:** Sulfamethoxazole/trimethoprim
- **DRUG:** Observation

## Key facts

- **NCT ID:** NCT02624440
- **Lead sponsor:** Henrik Gregersen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2016-07
- **Final completion:** 2017-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624440, "Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02624440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*